5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | BUY | SELL | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.71▼ | 1.71▼ | 1.71▼ | 1.70▼ | 1.75▼ |
MA10 | 1.72▼ | 1.69▲ | 1.69▲ | 1.68▲ | 1.65▲ |
MA20 | 1.70▼ | 1.69▲ | 1.72▼ | 1.73▼ | 1.36▲ |
MA50 | 1.70▼ | 1.72▼ | 1.69▲ | 1.60▲ | 1.41▲ |
MA100 | 1.76▼ | 1.69▲ | 1.70▼ | 1.34▲ | 1.20▲ |
MA200 | 1.71▼ | 1.72▼ | 1.74▼ | 1.50▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | 0.006▲ | -0.001▼ | -0.014▼ | 0.049▲ |
RSI | 46.252▼ | 47.304▼ | 48.139▼ | 50.807▲ | 57.484▲ |
STOCH | 39.394 | 87.619▲ | 72.655 | 43.750 | 70.667 |
WILL %R | -100.000▼ | -54.545 | -58.333 | -60.000 | -27.074 |
CCI | -96.078 | 72.534 | 41.360 | 13.639 | 60.246 |
CDL | $QNCX Doji Candlestick Pattern Detected | Set Alert |
Saturday, August 09, 2025 08:12 AM
Detailed price information for Quince Therapeutics Inc (QNCX-Q) from The Globe and Mail including charting and trades.
|
Monday, July 21, 2025 05:00 PM
Quince Therapeutics Stock Up 0.5% Shares of NASDAQ QNCX opened at $1.90 on Monday. The company has a quick ratio of 4.05, a current ratio of 4.05 and a debt-to-equity ratio of 0.82.
|
Tuesday, July 01, 2025 09:08 AM
Nasdaq handily beat the New York Stock Exchange in stock market listings during the first half of 2025, buoyed by blockbuster initial public offerings of big names like CoreWeave and Chime and a ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
15/08/25 | 1.68 | 1.755 | 1.63 | 1.69 | 166,060 |
14/08/25 | 1.74 | 1.775 | 1.66 | 1.68 | 128,177 |
13/08/25 | 1.82 | 1.85 | 1.72 | 1.72 | 256,720 |
12/08/25 | 1.58 | 1.93 | 1.5571 | 1.83 | 757,533 |
11/08/25 | 1.63 | 1.6701 | 1.53 | 1.60 | 236,137 |
08/08/25 | 1.67 | 1.69 | 1.59 | 1.65 | 188,611 |
07/08/25 | 1.65 | 1.7007 | 1.55 | 1.67 | 274,744 |
06/08/25 | 1.67 | 1.72 | 1.60 | 1.66 | 336,562 |
05/08/25 | 1.75 | 1.754 | 1.65 | 1.69 | 419,779 |
04/08/25 | 1.67 | 1.68 | 1.63 | 1.63 | 65,437 |
|
|
||||
|
|
||||
|
|